Skip to main content
Fig. 7 | Cancer Nanotechnology

Fig. 7

From: PEG-functionalized UiO-66 MOFs for targeted vincristine delivery: enhanced cytotoxicity in breast and ovarian cancer cell lines

Fig. 7

Cell cycle analysis using flow cytometry. A, B Cell cycle distribution in MDA-MB-231 and A2780 cells treated with UiO-66, VIN, UiO-66–VIN, and UiO-66–VIN–PEG. C, D Quantification of cell cycle phases (%) following treatment. Cells were exposed to half of their IC₅₀ concentration. Data are presented as means ± standard deviations (n = 3). Statistical significance: *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001

Back to article page